SCHEMBL6895602

SCHEMBL6895602

O=C1CN(S(=O)(=O)c2cccc(Br)c2)CCN1CC1CCN(c2ccncc2)CC1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LSS P48449 2/20 0.45
MBTD1 Q05BQ5 1/20 0.42
L3MBTL3 Q96JM7 1/20 0.42
CHRM1 P11229 4/20 0.41
TPSAB1 Q15661 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HIF1A Q16665 1/20 0.40
F10 P00742 4/20 0.39
MAPK1 P28482 1/20 0.37
GBA1 P04062 1/20 0.36
HTR7 P34969 1/20 0.36
HTR6 P50406 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6892059 0.99 LSS (0.44) LSSMBTD1L3MBTL3CHRM1TPSAB1
SCHEMBL8118785 0.89 F10 (0.48) LSSCHRM1TPSAB1F10HTR7
Hydrochloric Acid SCHEMBL7050686 0.88 F10 (0.47) LSSCHRM1TPSAB1F10HTR7
Hydrochloric Acid SCHEMBL6894374 0.87 LSS (0.47) LSSCHRM1TPSAB1CYP3A4CYP2C9
SCHEMBL6893878 0.86 LSS (0.44) LSSCHRM1TPSAB1CYP3A4CYP2C9
Hydrochloric Acid SCHEMBL6895872 0.85 LSS (0.43) LSSCHRM1TPSAB1CYP3A4CYP2C9
Hydrochloric Acid SCHEMBL6892161 0.85 LSS (0.41) LSSCHRM1TPSAB1CYP3A4CYP2C9
SCHEMBL8114940 0.85 TPSAB1 (0.55) LSSCHRM1TPSAB1MEN1KMT2A
Hydrochloric Acid SCHEMBL6894320 0.84 CHRM1 (0.48) LSSCHRM1TPSAB1SMN1; SMN2F10
SCHEMBL6896865 0.82 LSS (0.50) LSSMEN1KMT2ACYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6680312-B2 FOR THERAPY OF CARDIAC INFARCTION, CEREBRAL THROMBOSIS; INHIBIT ACTIVATED COAGULATION FACTOR X (FXA) TO SHOW ANTI-COAGULANT ACTIVITY TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-01-20 US disclosed
US-20020193382-A1 Sulfonamide derivatives, their production and use TAKEDA PHARMACEUTICAL COMPANY, LIMITED (JP) 2002-12-19 US disclosed
US-6403595-B1 ANTICOAGULANTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-06-11 US disclosed
EP-1054005-A1 SULFONAMIDE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF Takeda Chemical Industries, Ltd. (JP) 2000-11-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020193382-A1 Sulfonamide derivatives, their production and use F12, F11, F2 LSS 1250/4885MBTD1 2996/4885L3MBTL3 4876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.